Veeva’s FY27 guidance and AI‑driven Vault CRM revenue growth reinforce a bullish stance, as EPS beats reinforce fundamentals. The 50‑day MA has recently crossed above the 200‑day MA, indicating a sustained upward bias.

Market sentiment remains positive with multiple upgrades and a strong AI narrative propelling demand. Veeva’s consistent outperformance and client retention fuel optimism for continued upside.

Long‑term prospects remain bright due to AI‑enabled biopharma solutions, yet Michael Burry’s overvaluation warning introduces downside risk if valuation strains intensify. Nonetheless, the company’s strong fundamentals provide a cushion against short‑term volatility.

RSI sits around 60, signaling a healthy trend with low overbought pressure, and the price is above its 50‑day SMA, confirming momentum. These data‑driven signals support a bullish outlook for the near term.